Examining the Effectiveness of Self-Acceptance Group Therapy
Status
Conditions
Treatments
Details and patient eligibility
About
When people feel shame, they experience negative thoughts about themselves ("I'm a bad person") and urges to avoid others. Shame is related to many psychological problems, such as depression, social anxiety, and borderline personality disorder (BPD). Because there are currently no well-tested treatments for shame, this study will examine the utility of Self-Acceptance Group Therapy (SAGT). SAGT is short-term group therapy that addresses shame specifically. Changes in shame, mood, and behavior will be examined over the course of treatment and a one-month follow-up.
Based on theory and existing evidence, Hypothesis 1a is that individuals with elevated initial levels of shame will report improvements on all outcome measures (e.g., reductions in trait shame, increases in self-acceptance) from pre-treatment to post-treatment, and Hypothesis 1b is that these gains will be maintained at follow-up one month after treatment completion.
Full description
Shame is an unpleasant self-conscious emotion that can be experienced following unwanted outcomes and events (Lewis, 1971). Cognitively, shame involves the attribution of negative outcomes to global, stable characterological flaws (e.g., thinking "That happened because I am a bad person;" Tracy & Robins, 2006). Behaviorally, shame involves urges to avoid or withdraw from other people in order to hide perceived flaws (e.g., Lindsay-Hartz et al., 1995). Shame has been theoretically implicated in the development and maintenance of many forms of psychopathology and problematic behaviors, including depression, social anxiety, and borderline personality pathology (e.g., Beck & Alford, 2009; Clark & Wells, 1995; Rizvi et al., 2011; Schoenleber & Berenbaum, 2012). Indeed, research indicates that shame is ubiquitous in psychopathology (see Tangney & Dearing, 2002), resulting in increasing recognition that treatments specifically addressing shame are needed (see Dearing & Tangney, 2011). Although a few promising and potentially shame-relevant treatments have recently been described (Brown et al., 2011; Germer & Neff, 2013; Gilbert, 2011), no well-validated treatments currently exist and these novel treatments generally do not address both the cognitive and the behavioral components of shame.
Evidence that shame involves both problematic thinking patterns and maladaptive actions suggests that effective interventions for shame need to address each of these components. Indeed, there is some initial evidence that cognitive and behavioral therapy techniques can reduce shame, at least in response to specific triggers. For example, cognitive restructuring in the context of cognitive processing therapy has been found to reduce trauma-related self-blaming thoughts (Resick et al., 2002), and women instructed in how to use the dialectical behavior therapy opposite-action skill to address a specified shame trigger reported reductions in shame about the given trigger (Rizvi & Linehan, 2005).
Drawing from this literature, a shame-focused intervention, Self-Acceptance Group Therapy (SAGT), was developed to target both the cognitive and behavioral components of shame from a cognitive-behavior therapy framework. SAGT is an 8-week group treatment that involves psychoeducation and training in cognitive and behavioral shame-coping skills in order to promote improvements in self-acceptance, which is the conceptual opposite of shame. For example, group members are taught how to recognize and challenge shame-eliciting thoughts, as well as how to effectively discuss shame-eliciting topics with others in order to alleviate shame, foster adaptive social support, and enhance their ability to demonstrate self-kindness/compassion. As in other cognitive-behavior therapies, group members complete weekly homework assignments that allow them to practice their new skills. In addition, in-session activities are used to promote further skills practice and target the social disconnection created by shame. An initial version of SAGT was provided to 8 women Veterans at the G.V. (Sonny) Montgomery VA Medical Center by one of the researchers (Dr. Schoenleber). Preliminary data indicate that group members reported large reductions in trait shame (d = 1.55) and improvements in self-acceptance (d = 2.15). Based on feedback provided by these group members, an updated version of the SAGT protocol has been prepared. The primary aim of the present study is to examine whether the current version of Self-Acceptance Group Therapy is effective in improving shame, as well as emotional and interpersonal functioning among individuals with elevated shame.
Based on theory and existing evidence, Hypothesis 1a is that individuals with elevated initial levels of shame will report improvements on all outcome measures (e.g., trait shame, self-acceptance, psychiatric symptoms) from pre-treatment to post-treatment, and Hypothesis 1b is that these gains will be maintained at follow-up one month after treatment completion.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Eligible participants will be adults (age 18 or older) who are fluent in English (as all materials will be presented in English) and report elevated levels of trait shame on the Experience of Shame Scale (ESS) at screening. Specifically, based on past research, individuals must score at least 55 on the ESS screening items, which is consistent with levels of shame often reported by clinical samples. In addition, all interested individuals must have a therapist/case manager/psychiatrist who provides them with individual psychotherapy on a regular basis and for whom the participant is willing to sign an Authorization for Release of Health Information.
Exclusion criteria
- Individuals will be excluded from the present study if they do not report significant difficulties with shame (i.e. ESS screening item scores less than 55), do not have an individual therapist/case manager/psychiatrist who monitors and addresses their broader mental health concerns, are experiencing active psychosis (i.e. delusions and/or hallucinations), or are experiencing an episode of mania.
Trial design
Primary purpose
Allocation
Interventional model
Masking
35 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal